GUIDI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 4.151
AS - Asia 3.383
EU - Europa 2.468
AF - Africa 301
Continente sconosciuto - Info sul continente non disponibili 223
SA - Sud America 164
OC - Oceania 4
Totale 10.694
Nazione #
US - Stati Uniti d'America 4.052
SG - Singapore 1.087
IT - Italia 883
VN - Vietnam 815
CN - Cina 783
GB - Regno Unito 412
DE - Germania 313
HK - Hong Kong 217
SE - Svezia 182
FR - Francia 121
IN - India 112
BR - Brasile 107
NL - Olanda 106
BD - Bangladesh 92
TG - Togo 84
CI - Costa d'Avorio 83
RU - Federazione Russa 74
IE - Irlanda 68
UA - Ucraina 65
ZA - Sudafrica 59
KR - Corea 56
JP - Giappone 54
FI - Finlandia 50
CA - Canada 47
SC - Seychelles 37
CH - Svizzera 36
BG - Bulgaria 34
PH - Filippine 33
JO - Giordania 29
EE - Estonia 24
BE - Belgio 22
AR - Argentina 21
TH - Thailandia 21
TR - Turchia 19
AT - Austria 18
MX - Messico 16
NG - Nigeria 14
GR - Grecia 11
IQ - Iraq 11
PL - Polonia 11
EC - Ecuador 10
ES - Italia 10
JM - Giamaica 10
ID - Indonesia 8
SA - Arabia Saudita 8
TW - Taiwan 8
IR - Iran 7
KE - Kenya 7
LT - Lituania 7
CL - Cile 6
CO - Colombia 6
HN - Honduras 5
MY - Malesia 5
PK - Pakistan 5
AU - Australia 4
CR - Costa Rica 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BS - Bahamas 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
MA - Marocco 3
RO - Romania 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
HU - Ungheria 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GP - Guadalupe 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MF - Saint Martin 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RE - Reunion 1
SD - Sudan 1
Totale 10.471
Città #
Singapore 752
Ashburn 429
Southend 352
Fairfield 348
Chandler 338
Bologna 297
Santa Clara 231
San Jose 227
Hong Kong 200
Hanoi 196
Ho Chi Minh City 190
Houston 170
Seattle 160
Wilmington 158
Woodbridge 143
Ann Arbor 136
Hefei 125
Cambridge 118
Beijing 108
Council Bluffs 103
Princeton 92
Lomé 84
Abidjan 83
Dong Ket 78
Boardman 76
Dublin 68
Milan 65
Frankfurt am Main 63
Los Angeles 61
New York 56
Dallas 48
Lauterbourg 46
Turin 43
Falls Church 42
Seoul 42
Tokyo 41
Helsinki 39
Buffalo 38
Redmond 35
Jacksonville 34
Sofia 34
Westminster 34
Bern 30
Nanjing 30
Padova 29
Rome 29
Amman 28
Da Nang 26
San Diego 26
Munich 25
Haiphong 24
Johannesburg 24
Berlin 22
Brussels 21
Rimini 20
Shenyang 20
Florence 19
Guangzhou 19
Shanghai 19
Tianjin 18
Chicago 17
Amsterdam 16
Jinan 16
Hebei 15
The Dalles 15
Redondo Beach 14
Abeokuta 12
Bengaluru 12
Changsha 12
Hải Dương 12
London 12
Naples 12
Orem 12
Phoenix 12
Toronto 12
Wuhan 12
Nanchang 11
Redwood City 11
Saint Petersburg 11
Trento 11
Vienna 11
Zhengzhou 11
Bolzano 10
Castel Maggiore 10
Des Moines 10
Montreal 10
Philadelphia 10
Brooklyn 9
Ha Long 9
Dearborn 8
Kingston 8
Manila 8
Meldola 8
Qingdao 8
São Paulo 8
Taizhou 8
Bangkok 7
Biên Hòa 7
Bắc Ninh 7
Las Vegas 7
Totale 6.843
Nome #
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 315
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 315
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 293
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 274
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 260
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 259
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 245
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 236
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 232
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 230
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 227
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 225
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 221
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 220
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 209
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 208
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 204
Postnatal neurogenesis in the dentate gyrus of the guinea pig 202
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 200
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 190
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 189
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model 187
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 185
Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea pig before puberty 184
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 184
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 184
Sex differences in the hilar mossy cells of the guinea-pig before puberty. 182
Timing of therapies for downsyndrome: The sooner, the better 176
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 175
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 174
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 174
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 173
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome 160
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 160
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 159
Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with Down syndrome. 155
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 153
Is it possible to improve neurodevelopmental abnormalities in Down syndrome? 148
Fisiologia gastrointestinale 146
Dendritic phenotype and proliferation potency in the hippocampal dentate gyrus of the Ts66Yah model of Down syndrome 142
Postnatal neurogenesis in the hippocampal dentate gyrus and subventricular zone of the Goettingen minipig. 142
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 142
Targeting APP/AICD in Down syndrome 136
Neurogenesis impairment: An early developmental defect in Down syndrome 136
Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome 133
null 130
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 125
Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down sindrome 121
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 107
null 100
null 97
“Analisi dell’espressione genica in ippocampi di topi Ts65Dn sottoposti a trattamento adolescenziale con il BDNF-mimetico 7,8 diidrossiflavone” 85
Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty 83
null 83
“Administration of the BDNF mimetic 7,8-Dihydroxyflavone during adolescence rescues neuron maturation and improves hippocampus- dependent memory in the Ts65Dn mouse model of Down syndrome”. 74
“Il trattamento adolescenziale con il BDNF mimetico 7,8-diidrossiflavone influenza la metilazione del DNA nell'ippocampo del modello Ts65Dn di sindrome di Down” 71
“Effects of 7,8-dihydroxyflavone treatment on DNA methylation profiles of adolescent Ts65Dn mice hippocampus” 67
“Trattamento adolescenziale con il BDNF mimetico 7,8- diidrossiflavone: una strategia utile per migliorare lo sviluppo della fascia dentata ippocampica nel modello Ts65Dn di sindrome di Down”. 60
Effects of early environment on pyramidal neuron morphology in field CA1 of the guinea-pig 58
“Adolescence represents an important window of opportunity for the rescue of dendritic pathology with a BDNF mimetic in a mouse model of Down syndrome” 57
“Is it possible to prevent or counteract Alzheimer’s disease in Down syndrome with molecules with antioxidant and anti-inflammatory properties?” 56
“Early pharmacotherapies for the rescue of intellectual disability in Down syndrome” 55
“Trattamento neonatale con astaxantina veicolata tramite nanoparticelle: effetti sullo sviluppo ippocampale e sullo stress ossidativo nel modello murino Ts65D” 55
Sex differences in the hilar mossy cells of the guinea-pig before puberty 54
“Il trattamento con il polifenolo Polidatina migliora lo sviluppo cerebrale e la memoria ippocampo-dipendente nel topo Ts65Dn, modello di sindrome di Down” 53
“Effects of neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles on hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome” 52
Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide 51
“La somministrazione neonatale di astaxantina tramite nanoparticelle ha un effetto proproliferativo nel modello murino Ts65Dn” 51
“Neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles fosters hippocampal neurogenesis in a mouse model of Down syndrome” 48
Editorial: Synaptic plasticity across the lifespan: mechanisms, adaptation, and vulnerability 28
Neonatal Treatment with Astaxanthin-Loaded Stealth Solid Lipid Nanoparticles Activates the Impaired NRF2 Pathway and Reduces Hippocampal Oxidative Stress in a Mouse Model of Trisomy 21 15
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society 14
Totale 10.694
Categoria #
all - tutte 29.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022758 0 0 50 38 95 54 64 51 37 53 164 152
2022/20231.231 107 232 65 169 70 99 44 59 187 12 91 96
2023/2024343 23 62 19 40 22 68 3 8 4 25 40 29
2024/20251.479 94 112 107 119 269 74 128 71 28 120 91 266
2025/20263.927 322 261 246 292 417 328 366 183 835 293 227 157
2026/2027574 195 229 150 0 0 0 0 0 0 0 0 0
Totale 10.694